A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment
Clinical trial NCT05255133 · COMPLETED
Trial details
- NCT number
- NCT05255133
- Sponsor
- Universiteit Antwerpen
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2022-06-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.